|
Carbaryl | CAS 63-25-2 | ||
CH3NHCOOC10H7 | RTECS FC5950000 | ||
Synonyms & Trade Names alpha-Naphthyl N-methyl-carbamate, 1-Naphthyl N-Methyl-carbamate, Sevin® |
DOT ID & Guide 2757 151 |
Exposure Limits |
NIOSH REL: TWA 5 mg/m3 | ||
OSHA PEL: TWA 5 mg/m3 | |||
IDLH 100 mg/m3 | Conversion |
Physical Description White or gray, odorless solid. [pesticide] |
|||
MW: 201.2 |
BP: Decomposes |
MLT: 293°F |
Sol: 0.01% |
VP(77°F): <0.00004 mmHg |
IP: ? |
|
Sp.Gr: 1.23 |
Fl.P: NA |
UEL: NA |
LEL: NA |
|
Noncombustible Solid, but may be dissolved in flammable liquids. | |||
Incompatibilities & Reactivities Strong oxidizers, strongly alkaline pesticides |
Measurement Methods NIOSH 5006, 5601; OSHA 63 |
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
Respirator Recommendations
NIOSH/OSHA Up to 50 mg/m3: (APF = 10) Any supplied-air respirator* Up to 100 mg/m3: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode*/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Miosis, blurred vision, tear; rhinorrhea (discharge of thin mucus), salivation; sweating; abdominal cramps, nausea, vomiting, diarrhea; tremor; cyanosis; convulsions; irritation skin; possible reproductive effects | |
Target Organs
respiratory system, central nervous system, cardiovascular system, skin, blood cholinesterase, reproductive system |
See also: INTRODUCTION |